Prostamax Dosage Guide, Benefits & Side Effects

The evidence base for synthetic Prostamax (KEDP) itself is limited to animal (rat prostatitis/BPH model) and in vitro studies, mostly from the Khavinson research group, with no independent replication and no Western randomized controlled trials. Much stronger human clinical data exists for a related but distinct product, the bovine-derived extract Prostatilen (sold as Vitaprost in Russia), which should not be conflated with the synthetic tetrapeptide sold as Prostamax.

Because rigorous human trials are lacking, safety data are limited. User reports and vendor materials describe it as generally well tolerated, with occasional mild effects such as injection-site reactions (if injected), headache, or digestive discomfort. There is no comprehensive human safety profile, and effects in people with existing prostate conditions or other medications have not been systematically studied.

Lyophilized (freeze-dried) Prostamax powder is generally recommended to be stored frozen (around -20°C) before use and refrigerated (2-8°C) once reconstituted, similar to other lyophilized research peptides. Bacteriostatic or sterile water is typically used for reconstitution when the injectable form is used. Exact stability windows vary by supplier, so the product's specific certificate of analysis or safety data sheet should be consulted.

Prostamax is sold by peptide vendors labeled 'for research use only, not for human consumption,' meaning it is not an FDA-approved drug, food, cosmetic, or dietary supplement in the United States. It has not gone through Western clinical trials or regulatory review; any reported human use is off-label and outside the manufacturer's stated intent. Purchasers should understand it is being sold as a research chemical, not as a treatment for any condition, and should check local regulations before purchasing.